Anti-Amyloid Alzheimer's Drugs: Who Qualifies and What the 2026 Evidence Shows
Leqembi and Kisunla are the first drugs that slow early Alzheimer's. Here is who qualifies, the ARIA risk, Medicare coverage, and the realistic benefit to expect.
Dr. Elena Hartman, MD Aug 21, 2026 4 min read